Onderneming Respirerx Pharmaceuticals Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22-03-13 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22-03-13 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15-10-14 |
David Dickason
PRN | Corporate Officer/Principal | - | 15-09-20 |
Marc M. Radin
AUD | Comptroller/Controller/Auditor | - | 01-10-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22-03-13 |
Director/Board Member | - | 22-03-23 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22-03-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 365 418 647 | 341 184 734 ( 93,37 %) | 0 | 93,37 % |
Aandeel B | 0 | 37 500 | 0 | 0 |
Bedrijfsgegevens
RespireRx Pharmaceuticals, Inc.
126 Valley Road Suite C
07452, Glen Rock
+201 444 4947
http://www.respirerx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,45% | 124 mld. | |
+18,76% | 112 mld. | |
+3,52% | 22,94 mld. | |
-11,11% | 17,02 mld. | |
-16,50% | 16,88 mld. | |
-39,57% | 16,87 mld. | |
+2,77% | 13,63 mld. | |
+24,05% | 11,61 mld. | |
+106,37% | 10,31 mld. |
- Beurs
- Aandelen
- Koers RSPI
- Koers
- Onderneming Respirerx Pharmaceuticals Inc